意識の錬金術師 @the_nine_18 - Twitter Profile

🚨来た~!トランプは今回の演説を放送しなかった大手メディアの放送免許剥奪を求めた👏 🗣️トランプ:「NBCやABCといったフェイクニュースメディアはこの演説を報道しないと表明した。彼らは演説の内容を承知しており、我々のシステムがいかに腐敗しているかを暴かれたくないがゆえに、この話題を嫌った。メディア関係者は陰謀に加担している。このような不正行為は放送免許の取り消しに値する。彼らは何十億ドルもの価値がある公共の電波をタダ同然で利用しており、彼らは対価を一切支払っていない」

17

3K

733

189

69K

意識の錬金術師 @the_nine_18

3 months ago

@kana__143500 生きるために食うなら会社員食うために生きるなら事業主どちらにしてもメンタリティを上げて恐れを超えていかないとすぐに穴に潜りたくなってしまう

1

0

7K

the_nine_18 retweeted

わかるニュース📰 @wakaru_news_

4 months ago

【3年で1万人逮捕の"新型犯罪"】ニュースでよく聞く「トクリュウ」これ、ちゃんと説明できる？・指示役は28歳の夫婦・実行犯は全員16歳・栃木の事件もこの構造家族を守るために知っておくべき全部を4枚で図解しました🧵 #トクリュウ #栃木 #犯人 #闇バイト

wakaru_news_'s tweet photo. 【3年で1万人逮捕の"新型犯罪"】

ニュースでよく聞く「トクリュウ」
これ、ちゃんと説明できる？

・指示役は28歳の夫婦
・実行犯は全員16歳
・栃木の事件もこの構造

家族を守るために知っておくべき
全部を4枚で図解しました🧵

#トクリュウ #栃木 #犯人 #闇バイト https://t.co/1ynUCQ0YOD

10

560

246

238

275K

意識の錬金術師 @the_nine_18

3 months ago

エントロピー増大の法則からインプットした知識(m)は使わなければ価値は目減りしていく。だか、E=mc2から得た知識やスキルを高速でアウトプットする事で爆発的に成果を生み出すのだそうだ。今日からやってみよう！ここで重要なのは完璧を求めずとにかく早く出すことを心がけること。

the_nine_18's tweet photo. エントロピー増大の法則から
インプットした知識(m)は使わなければ価値は目減りしていく。
だか、E=mc2から
得た知識やスキルを高速でアウトプットする事で爆発的に成果を生み出すのだそうだ。

今日からやってみよう！

ここで重要なのは完璧を求めずとにかく早く出すことを心がけること。 https://t.co/ocVSO6OpZH

1

0

197

意識の錬金術師 @the_nine_18

3 months ago

メドベッドの眼版か！！

ScienceInFocus

@SciInFocus

3 months ago

Reading glasses might be done. The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours. One drop. Each eye. Per day. That's it. The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint. Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect. It was tested across more than 30,000 treatment days with no major complications. Cost is roughly $2 a day. This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it. LENZ Therapeutics, the maker, started rolling out samples in October. The squint era is ending. Source: Ynetnews, FOX 26 Houston, Yahoo News

SciInFocus's tweet photo. Reading glasses might be done.

The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours.

One drop. Each eye. Per day.

That's it.

The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint.

Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect.

It was tested across more than 30,000 treatment days with no major complications.

Cost is roughly $2 a day.

This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it.

LENZ Therapeutics, the maker, started rolling out samples in October.

The squint era is ending.

Source: Ynetnews, FOX 26 Houston, Yahoo News

463

10K

2K

8K

4M

0

1

0

255

the_nine_18 retweeted

ScienceInFocus

@SciInFocus

3 months ago

Reading glasses might be done. The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours. One drop. Each eye. Per day. That's it. The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint. Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect. It was tested across more than 30,000 treatment days with no major complications. Cost is roughly $2 a day. This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it. LENZ Therapeutics, the maker, started rolling out samples in October. The squint era is ending. Source: Ynetnews, FOX 26 Houston, Yahoo News

463

10K

2K

8K

4M